Reply to 'Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist!'
| Autor: | Siraya Jaijakul, Luis Ostrosky-Zeichner |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Microbiology (medical)
Male medicine.medical_specialty beta-Glucans business.industry Incidence (epidemiology) Ocular candidiasis Invasive candidiasis equipment and supplies bacterial infections and mycoses medicine.disease Dermatology eye diseases Clinical Practice fluids and secretions Endophthalmitis hemic and lymphatic diseases medicine Humans In patient Candidiasis Invasive Female business Letters to the Editor 1 3 β d glucan |
| Zdroj: | Journal of clinical microbiology. 51(5) |
| ISSN: | 1098-660X |
| Popis: | The incidence of ocular involvement in patients with candidemia, especially endophthalmitis, is relatively low. Patients who have a longer duration of candidemia have higher risk of developing ocular candidiasis ([1][1]). The current Infectious Diseases Society of America clinical practice |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|